Disparity in FcεRI-induced Degranulation of Primary Human Lung and Skin Mast Cells Exposed to Adenosine

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 2011 Mar 26

PMID 21437670

Citations 16

Authors

Gregorio Gomez

Wei Zhao

Lawrence B Schwartz

Affiliations

Soon will be listed here.

Abstract

Inhaled and intravenously administered adenosine induces mast cell-mediated (histamine-dependent) bronchospasm in asthmatics without causing urticaria. A differential response to adenosine by human lung and skin mast cells is shown: low concentrations potentiate FcεRI-induced degranulation of human lung mast cells but not that of skin mast cells. Human lung mast cells were found to express ∼ 3-fold more A3AR messenger RNA (mRNA) than skin mast cells, suggesting the involvement of the G(i)-linked A3AR. Indeed, the adenosine-induced potentiation was sensitive to inhibition by pertussis toxin and, furthermore, could be induced with an A3AR-specific agonist. This study reveals a previously unrecognized disparity in the response to adenosine by primary human mast cells from lung and skin that might explain why adenosine induces a pulmonary but not dermatologic allergy-like response in vivo. In addition, we identify the A3AR as a potentiating receptor of FcεRI-induced degranulation, thereby implicating it in the in vivo bronchoconstrictive response to adenosine in asthmatics.

Citing Articles

Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge.

Caiazzo E, Cerqua I, Turiello R, Riemma M, De Palma G, Ialenti A Biomolecules. 2022; 12(5).

PMID: 35625624 PMC: 9139122. DOI: 10.3390/biom12050697.

Adenosine Signaling in Mast Cells and Allergic Diseases.

Garcia-Garcia L, Olle L, Martin M, Roca-Ferrer J, Munoz-Cano R Int J Mol Sci. 2021; 22(10).

PMID: 34068999 PMC: 8156042. DOI: 10.3390/ijms22105203.

Immune-Mediated Mechanisms in Cofactor-Dependent Food Allergy and Anaphylaxis: Effect of Cofactors in Basophils and Mast Cells.

Munoz-Cano R, San Bartolome C, Casas-Saucedo R, Araujo G, Gelis S, Ruano-Zaragoza M Front Immunol. 2021; 11:623071.

PMID: 33679712 PMC: 7925840. DOI: 10.3389/fimmu.2020.623071.

Human Skin-Derived Mast Cells Spontaneously Secrete Several Angiogenesis-Related Factors.

McHale C, Mohammed Z, Gomez G Front Immunol. 2019; 10:1445.

PMID: 31293594 PMC: 6603178. DOI: 10.3389/fimmu.2019.01445.

Mast Cells and Their Progenitors in Allergic Asthma.

Mendez-Enriquez E, Hallgren J Front Immunol. 2019; 10:821.

PMID: 31191511 PMC: 6548814. DOI: 10.3389/fimmu.2019.00821.

References

Holgate S . The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma. Br J Pharmacol. 2005; 145(8):1009-15. PMC: 1576223. DOI: 10.1038/sj.bjp.0706272. View

Fredholm B, IJzerman A, Jacobson K, Klotz K, Linden J . International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001; 53(4):527-52. PMC: 9389454. View

Peachell P, Columbo M, Lichtenstein L, Marone G . Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis. 1988; 138(5):1143-51. DOI: 10.1164/ajrccm/138.5.1143. View

Auchampach J, Jin X, Wan T, Caughey G, Linden J . Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol. 1997; 52(5):846-60. DOI: 10.1124/mol.52.5.846. View

Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N . High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. J Biol Chem. 1991; 266(17):11245-51. View

Clarke H, Cushley M, Persson C, Holgate S . The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol. 1989; 2(3):147-54. DOI: 10.1016/0952-0600(89)90039-2. View

Baram D, Dekel O, Mekori Y, Sagi-Eisenberg R . Activation of mast cells by trimeric G protein Gi3; coupling to the A3 adenosine receptor directly and upon T cell contact. J Immunol. 2010; 184(7):3677-88. DOI: 10.4049/jimmunol.0901333. View

Polosa R, Ng W, Crimi N, Vancheri C, Holgate S, Church M . Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med. 1995; 151(3 Pt 1):624-9. DOI: 10.1164/ajrccm/151.3_Pt_1.624. View

Hua X, Chason K, Fredholm B, Deshpande D, Penn R, Tilley S . Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells. J Allergy Clin Immunol. 2008; 122(1):107-13, 113.e1-7. PMC: 4439463. DOI: 10.1016/j.jaci.2008.03.026. View

10.

Hillyard P, Nials A, SKIDMORE I, Vardey C . Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments. Br J Pharmacol. 1984; 83(2):337-45. PMC: 1987103. DOI: 10.1111/j.1476-5381.1984.tb16493.x. View

11.

Ryzhov S, Goldstein A, Matafonov A, Zeng D, Biaggioni I, Feoktistov I . Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol. 2004; 172(12):7726-33. DOI: 10.4049/jimmunol.172.12.7726. View

12.

Spicuzza L, Di Maria G, Polosa R . Adenosine in the airways: implications and applications. Eur J Pharmacol. 2006; 533(1-3):77-88. DOI: 10.1016/j.ejphar.2005.12.056. View

13.

Driver A, Kukoly C, Ali S, Mustafa S . Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993; 148(1):91-7. DOI: 10.1164/ajrccm/148.1.91. View

14.

Aridor M, Rajmilevich G, BEAVEN M, Sagi-Eisenberg R . Activation of exocytosis by the heterotrimeric G protein Gi3. Science. 1993; 262(5139):1569-72. DOI: 10.1126/science.7504324. View

15.

Cushley M, Tattersfield A, Holgate S . Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983; 15(2):161-5. PMC: 1427863. DOI: 10.1111/j.1365-2125.1983.tb01481.x. View

16.

Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield J, Sundstrom C . Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol. 1994; 39(5):489-98. DOI: 10.1111/j.1365-3083.1994.tb03404.x. View

17.

Phillips G, Rafferty P, Beasley R, Holgate S . Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma. Thorax. 1987; 42(12):939-45. PMC: 461055. DOI: 10.1136/thx.42.12.939. View

18.

Drake I, Routledge P, Richards R . Bronchospasm induced by intravenous adenosine. Hum Exp Toxicol. 1994; 13(4):263-5. DOI: 10.1177/096032719401300407. View

19.

Irani A, Bradford T, Kepley C, Schechter N, Schwartz L . Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989; 37(10):1509-15. DOI: 10.1177/37.10.2674273. View

20.

Peters S, Schulman E, Schleimer R, MacGlashan Jr D, Newball H, Lichtenstein L . Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis. 1982; 126(6):1034-9. DOI: 10.1164/arrd.1982.126.6.1034. View